mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.02 |